140 related articles for article (PubMed ID: 26212333)
1. LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer.
Xu Y; Zhang H; Nguyen VT; Angelopoulos N; Nunes J; Reid A; Buluwela L; Magnani L; Stebbing J; Giamas G
Cell Rep; 2015 Aug; 12(5):837-49. PubMed ID: 26212333
[TBL] [Abstract][Full Text] [Related]
2. LMTK3 confers chemo-resistance in breast cancer.
Stebbing J; Shah K; Lit LC; Gagliano T; Ditsiou A; Wang T; Wendler F; Simon T; Szabó KS; O'Hanlon T; Dean M; Roslani AC; Cheah SH; Lee SC; Giamas G
Oncogene; 2018 Jun; 37(23):3113-3130. PubMed ID: 29540829
[TBL] [Abstract][Full Text] [Related]
3. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
[TBL] [Abstract][Full Text] [Related]
4. Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response.
Hu C; Zhang S; Gao X; Gao X; Xu X; Lv Y; Zhang Y; Zhu Z; Zhang C; Li Q; Wong J; Cui Y; Zhang W; Ma L; Wang C
J Biol Chem; 2012 Jun; 287(23):18937-52. PubMed ID: 22496453
[TBL] [Abstract][Full Text] [Related]
5. The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁.
Xu Y; Zhang H; Lit LC; Grothey A; Athanasiadou M; Kiritsi M; Lombardo Y; Frampton AE; Green AR; Ellis IO; Ali S; Lenz HJ; Thanou M; Stebbing J; Giamas G
Sci Signal; 2014 Jun; 7(330):ra58. PubMed ID: 24939894
[TBL] [Abstract][Full Text] [Related]
6. LMTK3 is implicated in endocrine resistance via multiple signaling pathways.
Stebbing J; Filipovic A; Lit LC; Blighe K; Grothey A; Xu Y; Miki Y; Chow LW; Coombes RC; Sasano H; Shaw JA; Giamas G
Oncogene; 2013 Jul; 32(28):3371-80. PubMed ID: 22869149
[TBL] [Abstract][Full Text] [Related]
7. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
[TBL] [Abstract][Full Text] [Related]
8. The multifaceted role of lemur tyrosine kinase 3 in health and disease.
Ditsiou A; Gagliano T; Samuels M; Vella V; Tolias C; Giamas G
Open Biol; 2021 Sep; 11(9):210218. PubMed ID: 34582708
[TBL] [Abstract][Full Text] [Related]
9. The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
Cairns J; Ingle JN; Kalari KR; Shepherd LE; Kubo M; Goetz MP; Weinshilboum RM; Wang L
Breast Cancer Res; 2019 Apr; 21(1):47. PubMed ID: 30944027
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line.
Zhao G; Guo J; Li D; Jia C; Yin W; Sun R; Lv Z; Cong X
DNA Cell Biol; 2013 Dec; 32(12):699-707. PubMed ID: 24050776
[TBL] [Abstract][Full Text] [Related]
11. KAP1 promotes proliferation and metastatic progression of breast cancer cells.
Addison JB; Koontz C; Fugett JH; Creighton CJ; Chen D; Farrugia MK; Padon RR; Voronkova MA; McLaughlin SL; Livengood RH; Lin CC; Ruppert JM; Pugacheva EN; Ivanov AV
Cancer Res; 2015 Jan; 75(2):344-55. PubMed ID: 25421577
[TBL] [Abstract][Full Text] [Related]
12. LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.
Jiang T; Lu X; Yang F; Wang M; Yang H; Xing N
FEBS Open Bio; 2020 Oct; 10(10):2107-2121. PubMed ID: 32865871
[TBL] [Abstract][Full Text] [Related]
13. Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.
Giamas G; Filipović A; Jacob J; Messier W; Zhang H; Yang D; Zhang W; Shifa BA; Photiou A; Tralau-Stewart C; Castellano L; Green AR; Coombes RC; Ellis IO; Ali S; Lenz HJ; Stebbing J
Nat Med; 2011 Jun; 17(6):715-9. PubMed ID: 21602804
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy.
Puto LA; Brognard J; Hunter T
J Biol Chem; 2015 Jun; 290(25):15406-15420. PubMed ID: 25903140
[TBL] [Abstract][Full Text] [Related]
15. Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway.
Wang C; Yang M; Gu X; Gu Y
Bioengineered; 2021 Dec; 12(1):6594-6605. PubMed ID: 34516351
[TBL] [Abstract][Full Text] [Related]
16. Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression.
Li X; Lee YK; Jeng JC; Yen Y; Schultz DC; Shih HM; Ann DK
J Biol Chem; 2007 Dec; 282(50):36177-89. PubMed ID: 17942393
[TBL] [Abstract][Full Text] [Related]
17. LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma.
Klug LR; Bannon AE; Javidi-Sharifi N; Town A; Fleming WH; VanSlyke JK; Musil LS; Fletcher JA; Tyner JW; Heinrich MC
Oncogene; 2019 Feb; 38(8):1200-1210. PubMed ID: 30242244
[TBL] [Abstract][Full Text] [Related]
18. Defective ATM-Kap-1-mediated chromatin remodeling impairs DNA repair and accelerates senescence in progeria mouse model.
Liu B; Wang Z; Ghosh S; Zhou Z
Aging Cell; 2013 Apr; 12(2):316-8. PubMed ID: 23173799
[TBL] [Abstract][Full Text] [Related]
19. LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.
Stebbing J; Filipovic A; Ellis IO; Green AR; D'Silva TR; Lenz HJ; Coombes RC; Wang T; Lee SC; Giamas G
Breast Cancer Res Treat; 2012 Apr; 132(2):537-44. PubMed ID: 21671015
[TBL] [Abstract][Full Text] [Related]
20. KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin.
Kepkay R; Attwood KM; Ziv Y; Shiloh Y; Dellaire G
Cell Cycle; 2011 Jan; 10(2):308-22. PubMed ID: 21228624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
